• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Crucell N.V. - SWOT Analysis Product Image

Crucell N.V. - SWOT Analysis

  • Published: August 2011
  • Region: Global
  • 26 pages
  • Datamonitor

Crucell N.V. - SWOT Analysis company profile is the essential source for top-level company data and information. Crucell N.V. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Crucell is a biopharmaceutical company engaged in discovering, developing and commercializing vaccines and antibodies for the treatment of infectious diseases. The company's product portfolio is focused on three distinct areas: pediatric, travel and endemic, and respiratory. The company primarily operates in Europe, North America and Asia. It is headquartered in Leiden, the Netherlands and employed 1,400 people as of December 31, 2010. Johnson & Johnson completed the acquisition of Crucell for $2.3 billion in March 2011. The company recorded revenues of E365.4 million ($484.8 million-) during the financial year (FY) ended December 2010, an increase of 2.1% over FY2009. The operating loss of the company was E34.3 million ($45.5 million-) during FY2010, as compared with an operating profit of E39 million ($51.7 million-) in FY2009. The net loss was E27.6 million ($36.6 million-) READ MORE >

Key Facts: Crucell N.V.
Company Overview: Crucell N.V.
Business Description: Crucell N.V.
Company History: Crucell N.V.
Key Employees: Crucell N.V.
Key Employee Biographies: Crucell N.V.
Products & Services Listing: Crucell N.V.
Products & Services Analysis: Crucell N.V.
Company View: Crucell N.V.
Top Competitors: Crucell N.V.
Location and Subsidiary: Crucell N.V.
-Head Office: Crucell N.V.
-Other Locations and Subsidiaries: Crucell N.V.

Note: Product cover images may vary from those shown